ClinicalTrials.gg
RecruitingNCT07124676LAC-VAG-2025Updated Apr 28, 2026

Prospective Study Comparing Two Classification Systems for Second-degree Vaginal Tears During Spontaneous Childbirth to Assess Their Ability to Predict Postpartum Complications.

An observational study in Vaginal Laceration During Delivery, sponsored by University of Campania Luigi Vanvitelli. Recruiting at 1 site in Italy. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-28.

Sponsored by University of Campania Luigi Vanvitelli · Observational

From the registry’s dates

  • Started Nov 2025; still recruiting 1 year later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
482
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this observational study is to learn whether different classification systems for second-degree perineal tears can predict postpartum complications in women undergoing spontaneous vaginal childbirth. The main questions it aims to answer are:

Does the Scandinavian classification better predict postpartum complications such as hemoglobin drop, perineal pain, occult muscle injury, and sexual dysfunction? Does the De Simone classification better correlate with these same postpartum outcomes?

Researchers will compare the Scandinavian classification and the De Simone classification to see which system more accurately predicts clinically relevant postpartum complications.

Participants will:

Undergo standard clinical assessment after spontaneous vaginal delivery with a second-degree perineal tear Have their perineal tear classified using both the Scandinavian and De Simone systems Receive routine postpartum evaluation, including hemoglobin measurement, pain assessment (VAS), and perineal ultrasound Complete follow-up assessment of sexual function using the Female Sexual Function Index (FSFI)

Read the detailed description

Second-degree perineal tears are heterogeneous injuries involving the perineal muscles without anal sphincter involvement, and their anatomical variability may influence postpartum outcomes. Current standard classifications do not provide detailed subclassification, limiting risk stratification.

This prospective, single-center observational study evaluates the prognostic performance of two detailed classification systems: the Scandinavian classification (based on the extent of the perineal body) and the De Simone classification (based on vaginal extension and muscle involvement).

Participants are consecutively enrolled following spontaneous vaginal delivery with second-degree tears. Classification is performed during routine postpartum examination by trained clinicians using both systems, with independent assessment to minimize misclassification.

Data are collected prospectively and managed in a secure electronic database with predefined validation and consistency checks. Source data verification is performed against clinical records, and variables are standardized through a predefined data dictionary.

The statistical approach includes multivariable modeling to assess the association between tear subtypes and clinical outcomes, adjusting for relevant confounders. Model performance will be evaluated using standard calibration and discrimination metrics, with predefined strategies for handling missing data.

The study is non-interventional and conducted in accordance with Good Clinical Practice.

02

Conditions studied

  • Vaginal Laceration During Delivery

Browse trials for

Keywords

  • vaginal laceration
  • delivery
03

In context

Lacerations

174 studies on the registry are indexed under Lacerations; 43 are open to participants now.

This study's planned enrollment of 482 is above the median of 100 across 37 observational studies indexed under Lacerations.

Browse Lacerations studies →

Lead sponsor

University of Campania Luigi Vanvitelli is the lead sponsor of 174 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women giving birth, who experience a spontaneous vaginal delivery resulting in a spontaneous second-degree perineal tear. Participants are recruited consecutively from the hospital's maternity ward during the study period.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female at birth
  • Age ≥ 18 years
  • Spontaneous vaginal delivery
  • Presence of a spontaneous second-degree perineal tear confirmed on -postpartum examination
  • Ability and willingness to provide

Exclusion criteria

Exclusion Criteria:

  • Obstetric or medical conditions preventing spontaneous vaginal delivery
  • Inability to understand study procedures or complete follow-up assessments
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
482 participants (estimated)
Patient registry
No

Groups and cohorts

  • Women with spontaneous second-degree perineal tears

    Participants are women who have a spontaneous vaginal birth and sustain a spontaneous second-degree perineal tear. Each tear is classified according to both the Scandinavian (Macedo et al., 2022) and De Simone systems during routine postpartum examination. No experimental intervention is performed; outcomes are collected through clinical records, postpartum examination, ultrasound, and validated questionnaires (FSFI).

06

What researchers measure

Primary outcomes

  1. hemoglobin reduction

    significant hemoglobin reduction (\>2 g/dL from pre- to post-delivery)

    Time frame: within 48 hours postpartum

  2. moderate-to-severe perineal pain

    Visual Analog Scale (VAS) ≥ 5; (VAS; range 0-10, where 0 = no pain and 10 = worst imaginable pain); moderate-to-severe pain defined as VAS ≥ 5

    Time frame: within 48 hours postpartum

  3. pathological Female Sexual Function Index (FSFI) total score

    FSFI total score modification after vaginal laceration Female Sexual Function Index (FSFI total score; range 2-36, where lower scores indicate worse sexual function and higher scores indicate better function), evaluated as change from baseline

    Time frame: within 48 hours after the delivery

Secondary outcomes

  1. occult perineal or vaginal muscle lesions

    occult perineal or vaginal muscle lesions on postpartum perineal ultrasound;

    Time frame: within 7 days postpartum for ultrasound assessment; at 3 months postpartum for FSFI evaluation.

07

Study locations

1 of 1 sites recruiting
  • Universita degli studi della Campania "Luigi Vanvitelli" - dipartimento della donna, bambino e chirurgia generale e specialistica,
    Naples, Italy 80138, Italy
    Recruiting
08

References and documents

Publications

  • Macedo MD, Ellstrom Engh M, Siafarikas F. Detailed classification of second-degree perineal tears in the delivery ward: an inter-rater agreement study. Acta Obstet Gynecol Scand. 2022 Aug;101(8):880-888. doi: 10.1111/aogs.14369. Epub 2022 May 11. PubMed 35546433 ↗

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to institutional policies and ethical considerations regarding the protection of participants' privacy.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07124676
Responsible party
Marco La Verde (Researcher, University of Campania Luigi Vanvitelli) — Principal investigator
First posted
Aug 15, 2025
Start date
Nov 4, 2025
Primary completion
Nov 1, 2026 (estimated)
Completion
Oct 1, 2028 (estimated)
Last update
Apr 28, 2026

Study contacts

Marco La Verde, MD, researcher
Contact
marco.laverde@unicampania.it
+393389412266

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion